Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04131361
Other study ID # R.19.10.644
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date October 1, 2022
Est. completion date December 30, 2022

Study information

Verified date June 2023
Source Mansoura University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Background: Intravenous fluid replacement during transurethral resection of the prostate is still unclear. Ultrasonography of the inferior vena cava (IVC) has been recently used to assess the volume status and predict fluid responsiveness. In this double-blind, randomized controlled study, we will assess the IVC at baseline and at subsequent time points after spinal anesthesia, and according to IVC diameter will give the replacement challenge colloid. Potential problems during TURP are mostly due to either fluid overload or bleeding: Intraoperative TURP syndrome, Hemorrhage, Myocardial ischemia, Hypothermia, Prostatic capsular perforation, Bladder or urethral perforation. Postoperative TURP syndrome, myocardial ischemia/infarction, Postoperative cognitive impairment. Study Hypothesis: Strict colloid volume optimization using US-guided IVC diameter calculation aiming decrease the total IV fluid volume and accommodate the transurethral inevitable absorption of currently used irrigation crystalloid fluid (Nacl0.9%) that accidentally absorbed and change it from a circulatory overload to a complementary part of the replacement IV fluids preventing fluid overload and TURP syndrome. Aim of the work: To reduce Intraoperative and postoperative fluid overload during TURP surgery with hemodynamic stability relaying up on US-guided IVC diameter dependent Strict IV Colloid replacement volume optimization. Methods: A prospective randomized controlled trial on ASAI-III male patient aged 40-80 years old subjected to transurethral endoscopic resection of the prostate (TURP) surgery. Then patients will be divided into 2 groups according to the IV infusion fluid type as follow: Crystalloid -control group: (preload plus continuous IO Ringer acetate crystalloid 4/2/1 rule infusion) according to the usual 4/2/1 rule. Not guided by IVC diameter but IVC diameter will be calculated using the US and recorded at baseline just after spinal anesthesia and then every 30 minutes till the end of surgery. Loop Diuretic (Furosemide) will be given according to the maximum diameter of the IVC as follow; 10mg if IVC>2.5Cm. Colloid- study group: (preload plus colloid challenge only); Fluid challenge boluses of 250 mL (over 5 minutes using a pressurizer) 6% hydroxyethyl starch 130/0.4 in 0.9% sodium chloride (voluven®) if the IVC<1.7(higher limit of normal) will be given guided by IVC diameter at baseline just after spinal anesthesia and then every 30 minutes till the end of surgery.


Recruitment information / eligibility

Status Completed
Enrollment 34
Est. completion date December 30, 2022
Est. primary completion date December 25, 2022
Accepts healthy volunteers No
Gender Male
Age group 40 Years to 80 Years
Eligibility Inclusion Criteria: - Inclusion Criteria: - Patients subjected to transurethral resection of prostate TURP. - ASA I&II - Age 40-80years old. prostate size 45-100 - Surgical procedure: laser and Bipolar TURP using saline 0,9% irrigation. - Exclusion Criteria: - Height <150 cm. - Weight <60 kg. - Body mass index =45 kg/m2. - Contraindications to spinal anesthesia (increased intracranial pressure or local skin infection). - Uncontrolled; Diabetes mellitus, cardiovascular failure, cerebrovascular uncontrolled deficite, or other renal disease. - Hemoglobin <10 gm/dL. - International Normalized Ratio >1.4 - Platelet count <100,000 /mm3. - Preoperative serum creatinine >1.5 mg/dL

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Ultrasound-guided Inferior vena cava diameter dependent colloid challenge versus routine crystalloid strategy Fluid replacement
The inferior vena cava largest and smallest diameters will be measured proximal to the opening of the hepatic veins in the longitudinal axis with the M-mode using a 8-2 MHz curved array ultrasound probe placed longitudinally in the subcostal region.

Locations

Country Name City State
Egypt Anesthesia Department Mansoura Dakahlia

Sponsors (1)

Lead Sponsor Collaborator
Mansoura University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary total iv fluids just after end of surgery
Secondary serum Na at end of surgery just after end of surgery
Secondary serum K at end of surgery just after end of surgery
Secondary ximum and minimum IVC diameter serial during surgery
Secondary IVC-CI serial during surgery
Secondary Incidence of bradycardia serial during surgery
Secondary Incidence of hypo-tension serial during surgery
See also
  Status Clinical Trial Phase
Completed NCT05104528 - Non-Invasive Cardiometry and Ultrasound Guided Inferior Vena Cava Collapsibility Index in Assessing Fluid Responsiveness N/A
Completed NCT05070819 - Atrial Natriuretic Peptide in Assessing Fluid Status N/A
Completed NCT04556123 - Management of Fluid Overload in TAVR N/A
Completed NCT04645121 - Carbon Monoxide-based Rebreathing Method and Bioimpedance in Hemodialysis Patients
Completed NCT03505788 - Acetazolamide in Decompensated Heart Failure With Volume OveRload (ADVOR) Phase 4
Active, not recruiting NCT04882358 - Safety & Feasibility of DSR TherApy in Heart FAiluRe pAtients With Persistent Congestion N/A
Not yet recruiting NCT06414759 - Efficacy and Safety of Combination Diuretic Therapy in Patients With Acute Decompensated Heart Failure and Volume Overload Phase 4
Active, not recruiting NCT04334668 - Oral Sodium to Preserve Renal EfficiencY in Acute Heart Failure N/A
Withdrawn NCT01617798 - Stop Hypernatremia, Use Metolazone, for Aggressive, Controlled, Effective Diuresis N/A
Completed NCT04019314 - Assessment of ProEnkephalin to Detect Acute Kidney Injury (AKI) N/A
Completed NCT03194750 - Ultrasound Assessment of Volume in Patients on Continuous Dialysis N/A
Recruiting NCT05965934 - Management of Volume Overload HF Patients by Individual DSR Treatment adJustment-a clinicAl inVestigation of InfusatE2.0 Phase 1/Phase 2
Recruiting NCT05240833 - VExUS-guided Fluid Management in Patients With Acute Kidney Injury in the Intensive Care Unit N/A
Completed NCT04623281 - Haemodialysis Outcomes & Patient Empowerment Study 02
Completed NCT03168126 - Advanced Hemodynamic Monitoring in Free Flap Surgery N/A
Recruiting NCT05217342 - PVP-Guided Decongestive Therapy in HF Phase 4
Completed NCT04775576 - Comparison of Conventional Fluid Management Protocol With Targeted Pleth Variability Index (PVI) Monitoring Protocol During Total Abdominal Hysterectomy and Bilateral Salpingooferectomy Operation N/A
Completed NCT05735288 - Haemodialysis Outcomes & Patient Empowerment Study 03
Recruiting NCT05595395 - The Enteral Resuscitation In Intensive Care Pilot- Study N/A
Terminated NCT02769351 - Global rEgistry on decongestioN Therapy Using Less invasivE UltraFiltration